NHS rolls out ‘life-changing’ drug to help multiple sclerosis patients walk
Get the Well Enough newsletter with Harry Bullmore for tips on living a healthier, happier and longer life Get the Well Enough email with Harry Bullmore Get the Well Enough email with Harry Bullmore Thousands of people living with multiple sclerosis (MS) in England are set to benefit from a new twice-daily pill that significantly improves walking ability, which is now being rolled out on the NHS. Hailed as “life-changing,” fampridine marks a significant advancement as the first drug specifically designed to address walking difficulties associated with the incurable autoimmune disease. MS, which affects the brain and spinal cord, can manifest through a range of debilitating symptoms including tiredness, dizziness, tingling sensations, muscle cramps, vision problems, and memory issues. Until now, patients struggling with mobility have primarily relied on physiotherapy, walking aids, or supportive devices for their feet. The drug, also known as Fampyra, functions by acting as a signal booster within the nervous system. It works to restore electrical signals along damaged nerves, thereby enabling muscles to function more effectively and improving overall mobility …









